Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
NCT00559351Phase 3Terminated
- Sponsor
- Ministerstwo Nauki i Informatyzacji
- Start
- Dec 2001
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132), fluorouracil in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Ministerstwo Nauki i Informatyzacji. Started Dec 2001; status: terminated.
02
Drugs
Cisplatin micelle injection (HA132)fluorouracil
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT00559351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00559351.